All Stories

  1. Discovery of Bioactive Molecules via Miniaturized Parallel Modular Reactions and Rapid Screening (2016-2021 Update)

    Article • Mini-Reviews in Organic Chemistry, August 2022, Bentham Science Publishers

    Professor Peng Zhan, Professor Xinyong Liu

  2. SARS-CoV-2 Entry Inhibitors Targeting Virus-ACE2 or Virus-TMPRSS2 Interactions

    Article • Current Medicinal Chemistry, February 2022, Bentham Science Publishers

    Professor Xinyong Liu, Professor Peng Zhan

  3. Novel urate transporter 1 (URAT1) inhibitors: a review of recent patent literature (2016–2019)

    Article • Expert Opinion on Therapeutic Patents, October 2019, Taylor & Francis

    Professor Xinyong Liu, Professor Peng Zhan

  4. Update on Recent Developments in Small Molecular HIV-1 RNase H Inhibitors (2013-2016): Opportunities and Challenges

    Article • Current Medicinal Chemistry, May 2018, Bentham Science Publishers

    Professor Xinyong Liu, Professor Peng Zhan

  5. Novel fused pyrimidine and isoquinoline derivatives as potent HIV-1 NNRTIs: a patent evaluation of WO2016105532A1, WO2016105534A1 and WO2016105564A1

    Article • Expert Opinion on Therapeutic Patents, March 2017, Taylor & Francis

    Professor Xinyong Liu, Professor Peng Zhan

  6. Review of Small Synthetic Molecules Targeting HBV Capsid Assembly

    Article • Medicinal Chemistry, October 2015, Bentham Science Publishers

    Professor Xinyong Liu

  7. Meet Our Editorial Board Member

    Article • Letters in Drug Design & Discovery, June 2015, Bentham Science Publishers

    Professor Xinyong Liu

  8. The Changing Face of Hepatitis C: Recent Advances on HCV Inhibitors Targeting NS5A

    Article • Current Medicinal Chemistry, May 2015, Bentham Science Publishers

    Professor Xinyong Liu

  9. Medicinal Chemistry of Small Molecule CCR5 Antagonists for Blocking HIV-1 Entry: A Review of Structural Evolution

    Article • Current Topics in Medicinal Chemistry, September 2014, Bentham Science Publishers

    Professor Xinyong Liu

  10. Synthesis and Anti-HIV Activity of 4-(Naphthalen-1-yl)-1,2,5-thiadiazol-3-hydroxyl Derivatives

    Article • Chemical Biology & Drug Design, June 2014, Wiley

    Professor Xinyong Liu

  11. Design, synthesis and biological evaluation of novel trimethylpyrazine-2-carbonyloxy-cinnamic acids as potent cardiovascular agents

    Article • MedChemComm, January 2014, Royal Society of Chemistry

    Professor Xinyong Liu

  12. Ligustrazine Derivatives. Part 8: Design, Synthesis, and Preliminary Biological Evaluation of Novel Ligustrazinyl Amides as Cardiovascular Agents

    Article • Medicinal Chemistry, December 2013, Bentham Science Publishers

    Professor Yuemao Shen, Professor Xinyong Liu

  13. Design, Synthesis and Biological Evaluation of Substituted Guanidine Indole Derivatives as Potential Inhibitors of HIV-1 Tat-TAR Interaction

    Article • Medicinal Chemistry, November 2013, Bentham Science Publishers

    Professor Xinyong Liu

  14. Thiazolylthioacetamides as a Novel Class of Potential Antiviral Agents

    Article • Antiviral Research, May 2011, Elsevier

    Professor Xinyong Liu

  15. Designed Multiple Ligands: An Emerging Anti-HIV Drug Discovery Paradigm

    Article • Current Pharmaceutical Design, June 2009, Bentham Science Publishers

    Professor Xinyong Liu

  16. Recent Advances in Antiviral Activity of Benzo/Heterothiadiazine Dioxide Derivatives

    Article • Current Medicinal Chemistry, June 2008, Bentham Science Publishers

    Professor Xinyong Liu